000181141 001__ 181141
000181141 005__ 20240229145641.0
000181141 0247_ $$2doi$$a10.1016/j.annonc.2022.07.1941
000181141 0247_ $$2pmid$$apmid:35963481
000181141 0247_ $$2ISSN$$a0923-7534
000181141 0247_ $$2ISSN$$a1569-8041
000181141 0247_ $$2altmetric$$aaltmetric:134063898
000181141 037__ $$aDKFZ-2022-01794
000181141 041__ $$aEnglish
000181141 082__ $$a610
000181141 1001_ $$aVaz-Luis, Ines$$b0
000181141 245__ $$aESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.
000181141 260__ $$aAmsterdam [u.a.$$bElsevier$$c2022
000181141 3367_ $$2DRIVER$$aarticle
000181141 3367_ $$2DataCite$$aOutput Types/Journal article
000181141 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1667554861_9549
000181141 3367_ $$2BibTeX$$aARTICLE
000181141 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000181141 3367_ $$00$$2EndNote$$aJournal Article
000181141 500__ $$a2022 Nov;33(11):1119-1133
000181141 520__ $$aThe increased number of cancer survivors and the recognition of physical and psychosocial challenges, present from cancer diagnosis through active treatment and beyond, led to the discipline of cancer survivorship.and methods: Herein, we reflected on the different components of survivorship care, existing models, and priorities, in order to facilitate the promotion of high-quality European survivorship care and research.We identified five main components of survivorship care: (1) physical effects of cancer and chronic medical conditions; (2) psychological effects of cancer; (3) social, work and financial effects of cancer (4) surveillance for recurrences and second cancers; and (5) cancer prevention and overall health and well-being promotion. Survivorship care can be delivered by structured care models including but not limited to shared models integrating primary care and oncology services. The choice of the care model to be implemented has to be adapted to local realities. High quality care should be expedited by the generation of: (1) focused and shared European recommendations, (2) Creation of tools to facilitate implementation of coordinated care and (3) survivorship educational programs for health care teams and patients. The research agenda should be defined with the participation of health care providers, researchers, policy makers and patients and caregivers. The following patient centered survivorship research areas were highlighted: (1) generation of a big data platform to collect long-term real-world data in survivors and healthy controls to a) understand the resources, needs and preferences of cancer patients, and b) understand biological determinants of survivorship issues, and (2) develop innovative effective interventions focused on the main components of survivorship care.ESMO can actively contribute in the efforts of the oncology community towards a) promoting the development of high-quality survivorship care programs, b) providing educational material and c) aiding groundbreaking research by reflecting on priorities and by supporting research networking.
000181141 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000181141 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000181141 7001_ $$aMasiero, Marianna$$b1
000181141 7001_ $$aCavaletti, Guido$$b2
000181141 7001_ $$aCervantes, Andres$$b3
000181141 7001_ $$aChlebowski, Rowan T$$b4
000181141 7001_ $$aCurigliano, Giuseppe$$b5
000181141 7001_ $$aFelip, Enriqueta$$b6
000181141 7001_ $$aFerreira, Arlindo R$$b7
000181141 7001_ $$aGanz, Patricia A$$b8
000181141 7001_ $$aHegarty, Josephine$$b9
000181141 7001_ $$aJeon, Justin$$b10
000181141 7001_ $$aJohansen, Christoffer$$b11
000181141 7001_ $$aJoly, Florence$$b12
000181141 7001_ $$aJordan, Karin$$b13
000181141 7001_ $$aKoczwara, Bogda$$b14
000181141 7001_ $$aLagergren, Pernilla$$b15
000181141 7001_ $$aLambertini, Matteo$$b16
000181141 7001_ $$aLenihan, Daniel$$b17
000181141 7001_ $$aLinardou, Helena$$b18
000181141 7001_ $$aLoprinzi, Charles$$b19
000181141 7001_ $$aPartridge, Ann H$$b20
000181141 7001_ $$aRauh, Stefan$$b21
000181141 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b22$$udkfz
000181141 7001_ $$avan der Graaf, Winette$$b23
000181141 7001_ $$avan de Poll-Franse, Lonneke$$b24
000181141 7001_ $$aPentheroudakis, George$$b25
000181141 7001_ $$aPeters, Solange$$b26
000181141 7001_ $$aPravettoni, Gabriella$$b27
000181141 773__ $$0PERI:(DE-600)2003498-2$$a10.1016/j.annonc.2022.07.1941$$gp. S0923753422037929$$n11$$p1119-1133$$tAnnals of oncology$$v33$$x0923-7534$$y2022
000181141 909CO $$ooai:inrepo02.dkfz.de:181141$$pVDB
000181141 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b22$$kDKFZ
000181141 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000181141 9141_ $$y2022
000181141 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000181141 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000181141 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-09
000181141 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-09
000181141 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-09
000181141 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-09
000181141 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-09
000181141 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bANN ONCOL : 2021$$d2022-11-09
000181141 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-09
000181141 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-09
000181141 915__ $$0StatID:(DE-HGF)9950$$2StatID$$aIF >= 50$$bANN ONCOL : 2021$$d2022-11-09
000181141 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000181141 980__ $$ajournal
000181141 980__ $$aVDB
000181141 980__ $$aI:(DE-He78)C110-20160331
000181141 980__ $$aUNRESTRICTED